Complications, risks, and consequences
Estimatedfrequency
Most significant/serious complications
Early complications (≤90 days after surgery)
Infectiona
Wound
5–20 %
Intra-abdominal (including liver subphrenic abscess)
1–5 %
Intrathoracic (pneumonia; pleural, mediastinitis)
20–50 %
Systemic
1–5 %
Opportunistic (CMV, candidiasis, pneumocystis)a
50–80 %
Vascular/coagulation relateda
Bleeding and hematoma overall
20–50 %
Arterial, venous (caval, renal, portal, hepatic, or lobar vessels)
5–20 %
Raw liver surface
5–20 %
Extrahepatic
Chance of returning to the operating theatre for post-op bleeding
5–20 %
Vascular occlusion (all causes) (Non-thrombotic; partial or complete kinking; arterial stenosis)
5–20 %
Thrombosis
Hepatic arterial
1–5 %
Portal venous
1–5 %
Hepatic venous
0.1–1 %
IVC complications (stenosis; kinking)a
1–5 %
Coagulopathy (all causes)
20–50 %
Disseminated intravascular coagulopathy
0.1–1 %
Consumption posttransfusion (large bleed)a
1–5 %
Deep venous thrombosis
0.1–1 %
Liver relateda
Subcapsular liver hematomaa (major, at transplantation or liver biopsy)
5–20 %
Hepatitis (drug, CMV, recurrent)a
5–20 %
Primary liver transplant nonfunctiona
2–5 %
Common/extrahepatic/intrahepatic bile duct injury
1–5 %
Bile collections
1–5 %
Budd-Chiari (acute)a
0.1–1 %
GI relateda
Seroma/lymphocele formationa
20–50 %
Gastrointestinal injury, erosion, ulceration, perforation, hemorrhage
5–20 %
Pancreatic or duodenal injury/fistula/pancreatitis
1–5 %
Small bowel obstruction (early or late)a [Ischemic stenosis/adhesion formation]
1–5 %
Possibility of colostomy/ileostomy (very rare)a
<0.1 %
Splenic injury
0.1–1 %
Conservation (consequent limitation to activity; late rupture)
Splenectomy
Lung/chest relateda
Pneumothorax or pulmonary injury (direct)
50–80 %
Pleural effusionsa
20–50 %
Chest infectiona
5–20 %
Surgical emphysemaa(major)
1–5 %
Thoracic duct injury (chylous leak, fistula)a
1–5 %
Aspiration pneumonitis
0.1–1 %
Air embolus (major)
0.1–1 %
Diaphragmatic injury hernia or paresis
0.1–1 %
Cardiac relateda
Cardiac arrhythmias (major)
20–50 %
Pericardial effusion
1–5 %
Myocardial injury/cardiac failure infarction (hypotension)
1–5 %
Renal related
Acute renal failure (including hepatorenal syndrome)
5–20 %
Renal/adrenal injury renal veina
1–5 %
Metabolic
Hypoglycemia
5–20 %
Hyperglycemia
1–5 %
Neurological
Sleep disturbance, mental disturbance
50–80 %
Seizures
1–5 %
Cerebral edema
1–5 %
Wound dehiscencea
0.1–1 %
Multisystem organ failure (renal, pulmonary, cardiac failure)a
1–5 %
Early mortalitya
5–20 %
Intermediate complications (90–360 days after surgery)
Biliary related and fluid leaksa
Hyperbilirubinemia
50–80 %
Biliary and serous/lymph ascites
20–50 %
Bile duct obstruction (any cause) [Ischemia; stenosis]
5–20 %
Bile leak
5–20 %
Biliary collection
5–20 %
Biliary fistula
1–5 %
Persistent clinical jaundice
1–5 %
Rejectiona
Early/late acute/hyperacute
20–50 %
Chronic
0.1–1 %
Late complications (≥360 days after surgery)
Chronic liver rejectiona
5–20 %
Neurologicala(peripheral and central nervous systems)
5–20 %
Chronic renal failure (5–10 years)a
20–50 %
Immunosuppression toxicitya
5–20 %
Posttransplant malignancies (long term)a
Skin cancers (long term)a
>80 %
Lymphoproliferative disorders (lymphoma)a
5–20 %
Carcinomasa
Individual
Recurrence of malignancy (if transplanted for malignancy)a
Individual
Recurrent cirrhosis (all causes)a [Hep B, C, alcohol, biliary cirrhosis, sclerosing cholangitis, autoimmune hepatitis]
20–50 %
Biliarya(all causes: stones, stenosis, recurrent cholangitis, sclerosis)
5–20 %
Metabolic
Hyperlipidemia
20–50 %
Hyperglycemia
5–20 %
Osteoporosis
5–20 %
Graft-versus-host disease (GVHD)a
0.1–1 %
Graft lossa
1 year (~10 %)b
5–20 %
5 year (~25 %)b
20–50 %
Late mortalitya
5–20 %
Less serious complications